Multiple Myeloma Management
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
Hide..
Show more..
Screenshots
User Rating
0 out of 5
0 ratings in Brazil
Ratings History
Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
Living With
The Living With app
|
0
|
3 months ago | |
NephRef
|
0
|
2 years ago | |
Multiple Myeloma Manager
from @Point of Care
|
0
|
8 months ago | |
KUCC Clinical Trial Finder
KUCC Clinical Trial Finder
|
0
|
3 weeks ago | |
Graft Care
|
0
|
2 years ago | |
Multiple Myeloma [MM]
From @Point of Care™
|
0
|
1 month ago | |
Cancer Distress Coach
|
0
|
2 years ago | |
SurvivorNet
|
0
|
1 year ago | |
eKare inSight CR
Clinical Research for Wound
|
0
|
3 weeks ago | |
HealthTree
|
0
|
1 week ago |
Show More
Revenue and Downloads
Gain valuable insights into Multiple Myeloma Management performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- UMA MLG, LLC
- Languages
- English
- Recent version
- 1.0 (1 year ago )
- Released on
- May 26, 2023 (1 year ago )
- Also available in
- Hungary, United States, Taiwan, Thailand, Singapore, Saudi Arabia, Romania, Portugal, Poland, Philippines, Norway, Mexico, Kuwait, Italy, Ireland, United Arab Emirates, Greece, France, Ecuador, Algeria, Dominican Republic, Germany, Chile, Switzerland, Canada, Brazil, Belgium, Azerbaijan, Australia, Austria
- Last updated
- 4 days ago